Long-term Follow up After SG vs RYGB vs OAGB

Hospital General Universitario Elche600 enrolled

Overview

A prospective randomized clinical study of all morbidly obese patients undergoing SG, RYGB and OAGB, as primary bariatric procedures, was performed. Patients were randomly assigned into 3 groups: those patients undergoing SG, those ones undergoing RYGB and those ones undergoing OAGB. BMI, excess BMI loss (EBMIL) and remission of type 2 diabetes (T2DM), hypertension (HT) and dyslipidemia (DL) were assessed.

A prospective randomized clinical study of all morbidly obese patients undergoing SG, RYGB and OAGB, as primary bariatric procedures, was performed. Patients were randomly assigned into 3 groups: those patients undergoing Sleeve Gastrectomy, those ones undergoing Roux-en-Y Gastric Bypass and those ones undergoing One-Anastomosis Gastric Bypass. Body Mass Index (BMI), excess BMI loss (EBMIL) and remission of type 2 diabetes (T2DM), hypertension (HT) and dyslipidemia (DL) were assessed.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

600

Conditions

Weight Loss

Interventions

Sleeve GastrectomyPROCEDURE

The patients undergo a Sleeve Gastrectomy as bariatric procedure

Roux-en-Y gastric bypassPROCEDURE

The patients undergo a Roux-en-Y gastric bypass as bariatric procedure

One-Anastomosis Gastric BypassPROCEDURE

The patients undergo a One-Anastomosis Gastric Bypass as bariatric procedure

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * body mass index (BMI) \>40 Kg/m2 * BMI \> 35 Kg/m2 with the presence of comorbidities associated to obesity * age older than 18 years * Patients willing to participate in the study and giving their written consent Exclusion Criteria: * patients undergoing other bariatric techniques than SG, RYGB and OAGB * Patients undergoing any other surgical procedure added to the bariatric surgery * patients with medical or surgical pathologies that at the discretion of the investigators do not allow their participation in the study * inability to understand the nature and purpose of the study and / or to accept written participation in the study * impossibility to comply with pre-established clinical follow-up.

Outcomes

Primary Outcomes

Weight loss

The postoperative weight loss is investigated at 1, 2 and 5 years after surgery

Time frame: 1 , 2 and 5 years after surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.